Gillian Booth

MD, MSc

Scientist

Biography

Dr. Gillian Booth is a Scientist at MAP Centre for Urban Health Solutions within the Li Ka Shing Knowledge Institute of St. Michael’s Hospital in Toronto. Dr. Booth is also an Adjunct Scientist at the Institute for Clinical Evaluative Sciences (ICES), a Professor in the Department of Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto, and a practicing endocrinologist. Dr. Booth’s research focuses on health outcomes related to diabetes; specifically how socioeconomic, environmental and health care factors influence the risk of diabetes and its complications. She has extensive experience in using large provincial health care and survey databases, and in using geographic information systems (GIS) methodology to study contextual factors influencing the development of diabetes. One of her major research interests is on the built environment and its role in the obesity and diabetes epidemics. Dr. Booth has made major contributions to diabetes policy and practice at both the national and provincial levels. She has served on several advisory committees for the Public Health Agency of Canada’s Canadian Chronic Disease Surveillance System and she was the Methodology Chair for the 2013 Canadian Diabetes Association Clinical Practice Guidelines.

 

Recent Publications

  1. McSweeney, B, Campbell, RB, Grewal, EK, Booth, GL, Tariq, H, Campbell, DJT et al.. Accessing Diabetes Specialty Care for Persons With Lived Experience of Homelessness in Canada: Challenges and Opportunities. Can J Diabetes. 2022; :. doi: 10.1016/j.jcjd.2022.05.007. PubMed PMID:35811235 .
  2. Abdel-Qadir, H, Akioyamen, LE, Fang, J, Pang, A, Ha, ACT, Jackevicius, CA et al.. Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study. Circulation. 2022;146 (3):159-171. doi: 10.1161/CIRCULATIONAHA.122.058949. PubMed PMID:35678171 PubMed Central PMC9287095.
  3. Im, JHB, Escudero, C, Zhang, K, Choi, D, Sivakumar, A, Booth, GL et al.. Perceptions and Correlates of Distress Due to the COVID-19 Pandemic and Stress Management Strategies Among Adults With Diabetes: A Mixed-Methods Study. Can J Diabetes. 2022;46 (3):253-261. doi: 10.1016/j.jcjd.2021.10.006. PubMed PMID:35568426 PubMed Central PMC8531237.
  4. Kavanagh, ME, Chiavaroli, L, Glenn, AJ, Heijmans, G, Grant, SM, Chow, CM et al.. A Web-Based Health Application to Translate Nutrition Therapy for Cardiovascular Risk Reduction in Primary Care (PortfolioDiet.app): Quality Improvement and Usability Testing Study. JMIR Hum Factors. 2022;9 (2):e34704. doi: 10.2196/34704. PubMed PMID:35451981 PubMed Central PMC9073604.
  5. McGavock, J, Hobin, E, Prior, HJ, Swanson, A, Smith, BT, Booth, GL et al.. Multi-use physical activity trails in an urban setting and cardiovascular disease: a difference-in-differences analysis of a natural experiment in Winnipeg, Manitoba, Canada. Int J Behav Nutr Phys Act. 2022;19 (1):34. doi: 10.1186/s12966-022-01279-z. PubMed PMID:35346244 PubMed Central PMC8962160.
  6. den Braver, NR, Lakerveld, J, Gozdyra, P, van de Brug, T, Moin, JS, Fazli, GS et al.. Development of a neighborhood drivability index and its association with transportation behavior in Toronto. Environ Int. 2022;163 :107182. doi: 10.1016/j.envint.2022.107182. PubMed PMID:35306254 .
  7. Tobin, M, Hajna, S, Orychock, K, Ross, N, DeVries, M, Villeneuve, PJ et al.. Rethinking walkability and developing a conceptual definition of active living environments to guide research and practice. BMC Public Health. 2022;22 (1):450. doi: 10.1186/s12889-022-12747-3. PubMed PMID:35255841 PubMed Central PMC8900439.
  8. Howell, NA, Booth, GL. The weight of place: Built environment correlates of obesity and diabetes. Endocr Rev. 2022; :. doi: 10.1210/endrev/bnac005. PubMed PMID:35201344 .
  9. Cefalu, WT, Andersen, DK, Arreaza-Rubín, G, Pin, CL, Sato, S, Verchere, CB et al.. Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes. 2021; :. doi: 10.2337/db21-0777. PubMed PMID:34957490 .
  10. Cefalu, WT, Andersen, DK, Arreaza-Rubín, G, Pin, CL, Sato, S, Verchere, CB et al.. Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases. Can J Diabetes. 2021;45 (8):697-713. doi: 10.1016/j.jcjd.2021.09.126. PubMed PMID:34794897 .
Search PubMed

Affiliations & Other Activities

  • Division of Endocrinology, Department of Medicine, St. Michael’s Hospital
  • Associate Professor, Department of Medicine, University of Toronto
  • Institute of Health Policy, Management, & Evaluation, University of Toronto
  • Scientist, Institute of Clinical Evaluative Sciences